Detailed Narrative
Strong Financial Turnaround in FY25
Asahi Songwon reported a robust financial performance for FY25, with revenues increasing by 32% to 566 crores from 429 crores in FY24. This growth was accompanied by a significant 185% surge in EBITDA to 60 crores, leading to a doubling of EBITDA margins from 5% to 10%. The company successfully transitioned from a negative PAT in FY24 to a positive PAT of 17 crores in FY25, indicating a strong turnaround in profitability.
Improved Cash Flow and Debt Reduction
The company demonstrated strong cash flow generation, with operating cash flow improving substantially from 9 crores in FY24 to 57 crores in FY25. This was attributed to better management of payables, receivables, and inventory levels. Concurrently, Asahi Songwon focused on deleveraging, reducing its total debt from 200 crores in March 2024 to 160 crores in March 2025. The debt-to-equity ratio improved from 0.75 to 0.55, and EBITDA-to-debt dropped to 2.5 times.
AZO Business: Capitalizing on Tariff Opportunities
The AZO pigment business is set to benefit from anti-dumping duties of 20-30% imposed on Chinese imports, particularly in the US market. Management anticipates commercial opportunities to reflect in performance by the next quarter, with expectations of securing large quantity orders from 1-2 customers by year-end. A new yellow pigment line, involving a capex of approximately 5 crores, is expected to be fully operational within 3-4 months, adding 40 tons to the existing capacity.
API Segment: Diversification Amidst Price Pressure
Despite a challenging environment marked by a ~15% price crash for key API products like Pregabalin, the API segment achieved a 25% increase in volumes. The company is strategically moving towards becoming a multi-product API company, planning to launch new molecules and pursue backward integration for some over the next two years. This strategy aims to enhance profitability and reduce dependency on single products, with a target of 10-11% EBITDA margins for the full year.
Positive Outlook and Growth Targets for FY26
Asahi Songwon provided optimistic guidance for the next financial year (FY26), projecting a 15% top-line growth, 25% EBITDA growth, and 65% PBT growth. The company expects AZO capacity utilization to reach 80-85%, driving a 26-27% top-line growth (from 70 crores to 90 crores) and 8-10% EBITDA for the segment. Overall, consolidated EBITDA margins are targeted at around 12% in the coming years, with a long-term ROCE target of 15%.
Blue Business Stability and Efficiency Focus
The core blue pigment business continues to operate at a high capacity utilization of 85-87%. While the demand environment for pigments remains tepid, management is confident in sustaining gross margins through ongoing engineering and efficiency improvements. This segment is expected to provide stable performance, although significant growth is not anticipated due to the challenging industry landscape.